Evaluating the Impact of Patient Recruitment and Retention Practices

Drug Information Journal

Volumn 46, Issue 5, 2012, Pages 573-580

  Lamberti, Mary Jo ^a   Mathias, Adam ^a   Myles, Jane E ^b   Howe, Deborah ^c   Getz, Ken ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

global clinical trials; patient recruitment; retention

Indexed keywords

ADVERTIZING; ARTICLE; CLINICAL TRIAL (TOPIC); DATA COLLECTION METHOD; DRUG INDUSTRY; EVALUATION RESEARCH; HUMAN; MAJOR CLINICAL STUDY; PATIENT PARTICIPATION; PATIENT RECRUITMENT; PATIENT REFERRAL; PATIENT RETENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; TELECOMMUNICATION;

EID: 84873809871     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/0092861512453040     Document Type: Article

References (8)

1. Lovato L,Hill K,Hertert S,Hunninghake D,Probstfield J.Recruitment for controlled clinical trials: literature summary and annotated bibliography.Control Clin Trials. 1997;18:328-352.
2. Sung N,Crowley W,Genel M, et al.Central challenges facing the national clinical research enterprise.JAMA. 2003;289:1278-1287.
3. GlassH.What bothers clinical investigators?Informa UK. http://www.GCPj.com. Published July 2009.
4. Getz K,Wenger J.Assessing the impact of protocol design change on clinical trial performance.Am J Ther. 2008;15:449-456.
5. Lai G,Gary T,Tilburt J, et al.Effectiveness of strategies to recruit underrepresented populations into cancer clinical trials.Clin Trials. 2006;3 (2): 133-141.
6. McAnulty J.Bringing patient recruitment into our digital world.Drug Inf J. 2009;43:501-508.
7. Li G.Site activation: the key to more efficient clinical trials. PharmExec.com.Advanstar Communication. 2008; (December 12).
8. ThomaselliR. FDA's social-media "guidelines" befuddle big pharma. http://www.adage.com. Accessed December 30, 2011.